Gastroesophageal Cancers
-
Post ASCO GI Update: The Impact of the Matterhorn Clinical Trial on the Management of Gastric Cancer
Samuel J. Klempner, MD; Zev A. Wainberg, MD
-
Emerging Role of Fibroblast Growth Factor Receptor 2b (FGFR2b) Inhibitors in Gastroesophageal Cancers
Tanios S. Bekaii-Saab, MD
